Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report

Detalhes bibliográficos
Autor(a) principal: Saldanha, Inês
Data de Publicação: 2019
Outros Autores: Matos, Ricardo, Órfão, Tiago, Santos, Margarida
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397
Resumo: New generation oral anticoagulants — rivaroxaban, apixaban and edoxaban — represent an important medical achievement. Their therapeutic effectiveness and ease of use make them essential in the management of thromboembolic conditions. However, as warfarin, they have known haemorrhagic risks. This paper reports the case of a 50-year-old female who presented with ear pain and spontaneous blood discharge in her right ear, after a two-week treatment with rivaroxaban. The physical examination revealed a spontaneous tympanic haematoma in the inferior quadrants, adjacent to the umbus. She denied any manipulation of the ear canal. Our goal is to alert for a presumable side effect of this drug in clinical practise.
id RCAP_f02d07c5c4db916c11f15267e98b4552
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/9397
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case ReportHematoma Timpânico em Doente sob Rivaroxabano: Um Caso ClínicoHematoma/etiologyRivaroxaban/adverse effectTympanic MembraneHematoma/etiologiaMembrana TimpânicaRivaroxabano/efeitos adversosNew generation oral anticoagulants — rivaroxaban, apixaban and edoxaban — represent an important medical achievement. Their therapeutic effectiveness and ease of use make them essential in the management of thromboembolic conditions. However, as warfarin, they have known haemorrhagic risks. This paper reports the case of a 50-year-old female who presented with ear pain and spontaneous blood discharge in her right ear, after a two-week treatment with rivaroxaban. The physical examination revealed a spontaneous tympanic haematoma in the inferior quadrants, adjacent to the umbus. She denied any manipulation of the ear canal. Our goal is to alert for a presumable side effect of this drug in clinical practise.A nova geração de anti-coagulantes orais — rivaroxabano, apixabano e edoxabano — constitui um avanço significativo na medicina. Estes fármacos têm, atualmente, um papel fundamental no tratamento de doenças tromboembólicas, pela sua facilidade de administração. No entanto, tal como a varfarina, têm efeitos adversos, nomeadamente aqueles relacionados com o risco hemorrágico. Neste artigo, apresentamos o caso de uma doente de 50 anos de idade, do género feminino, que se apresentou no serviço de urgência com otalgia e otorragia espontânea à direita, após duas semanas de tratamento com rivaroxabano em dose profilática. No exame objetivo, destacava-se a presença de hematoma nos quadrantes inferiores do tímpano, adjacente ao umbus. Não havia história de manipulação do ouvido. O nosso objetivo é alertar para um provável efeito adverso deste fármaco, na prática clínica.Ordem dos Médicos2019-06-28info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfimage/jpegapplication/pdfimage/jpegapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397oai:ojs.www.actamedicaportuguesa.com:article/9397Acta Médica Portuguesa; Vol. 32 No. 6 (2019): June; 469-470Acta Médica Portuguesa; Vol. 32 N.º 6 (2019): Junho; 469-4701646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/5717https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/9772https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/9774https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/9775https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/10667https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/10773Direitos de Autor (c) 2019 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessSaldanha, InêsMatos, RicardoÓrfão, TiagoSantos, Margarida2022-12-20T11:05:44Zoai:ojs.www.actamedicaportuguesa.com:article/9397Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:42.633216Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report
Hematoma Timpânico em Doente sob Rivaroxabano: Um Caso Clínico
title Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report
spellingShingle Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report
Saldanha, Inês
Hematoma/etiology
Rivaroxaban/adverse effect
Tympanic Membrane
Hematoma/etiologia
Membrana Timpânica
Rivaroxabano/efeitos adversos
title_short Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report
title_full Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report
title_fullStr Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report
title_full_unstemmed Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report
title_sort Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report
author Saldanha, Inês
author_facet Saldanha, Inês
Matos, Ricardo
Órfão, Tiago
Santos, Margarida
author_role author
author2 Matos, Ricardo
Órfão, Tiago
Santos, Margarida
author2_role author
author
author
dc.contributor.author.fl_str_mv Saldanha, Inês
Matos, Ricardo
Órfão, Tiago
Santos, Margarida
dc.subject.por.fl_str_mv Hematoma/etiology
Rivaroxaban/adverse effect
Tympanic Membrane
Hematoma/etiologia
Membrana Timpânica
Rivaroxabano/efeitos adversos
topic Hematoma/etiology
Rivaroxaban/adverse effect
Tympanic Membrane
Hematoma/etiologia
Membrana Timpânica
Rivaroxabano/efeitos adversos
description New generation oral anticoagulants — rivaroxaban, apixaban and edoxaban — represent an important medical achievement. Their therapeutic effectiveness and ease of use make them essential in the management of thromboembolic conditions. However, as warfarin, they have known haemorrhagic risks. This paper reports the case of a 50-year-old female who presented with ear pain and spontaneous blood discharge in her right ear, after a two-week treatment with rivaroxaban. The physical examination revealed a spontaneous tympanic haematoma in the inferior quadrants, adjacent to the umbus. She denied any manipulation of the ear canal. Our goal is to alert for a presumable side effect of this drug in clinical practise.
publishDate 2019
dc.date.none.fl_str_mv 2019-06-28
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397
oai:ojs.www.actamedicaportuguesa.com:article/9397
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/9397
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/5717
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/9772
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/9774
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/9775
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/10667
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/9397/10773
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2019 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2019 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
image/jpeg
application/pdf
image/jpeg
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 32 No. 6 (2019): June; 469-470
Acta Médica Portuguesa; Vol. 32 N.º 6 (2019): Junho; 469-470
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130647543939072

Registros relacionados